Journal of the National Comprehensive Cancer Network

Journal of the National Comprehensive Cancer Network is a monthly peer-reviewed journal published by Harborside Press on behalf of the National Comprehensive Cancer Network, covering oncology and the NCCN Clinical Practice Guidelines. Founded in 2003, it is a leading journal in oncology, with a 2025 impact factor of 17.5, indexed in SCIE.《美国国家综合癌症网络杂志》（Journal of the National Comprehensive Cancer Network）是由 Harborside Press 代表美国国家综合癌症网络出版的月度同行评审期刊，涵盖肿瘤学与 NCCN 临床实践指南。该刊创刊于 2003 年，是肿瘤学领域的领军期刊，2025 年影响因子为 17.5，被 SCIE 收录。

Scope

The journal's stated aim is to publish original research and content that supports the mission of the National Comprehensive Cancer Network to improve the quality, effectiveness, and efficiency of cancer care, with its official scope covering:刊物官方宗旨为发表支持美国国家综合癌症网络提高癌症治疗质量、有效性与效率使命的原创研究与内容，官方声明的征稿范围包括：

NCCN Guidelines updates: publication of the NCCN Clinical Practice Guidelines in Oncology, including updates, adaptations, and translations of the guidelines for specific cancers.NCCN 指南更新：发表 NCCN 肿瘤学临床实践指南，包括特定癌症指南的更新、改编与翻译。
Original oncology research: original research articles on cancer prevention, detection, diagnosis, treatment, and survivorship across all tumor types.原创肿瘤学研究：关于所有肿瘤类型癌症预防、检测、诊断、治疗与生存的原创研究论文。
Clinical guidelines and outcomes: studies on the implementation, dissemination, and outcomes of clinical practice guidelines and quality measures in oncology.临床指南与结局：关于肿瘤学临床实践指南与质量措施实施、推广与结局的研究。
Health policy and disparities: research on health policy, health disparities, and access to cancer care, including cost-effectiveness and comparative effectiveness research.卫生政策与差距：关于卫生政策、健康差距与癌症治疗可及性的研究，涵盖成本效益与比较效果研究。
Article types: NCCN Guidelines, original research articles, reviews, editorials, commentaries, and special reports on topics of interest to the oncology community.栏目设置：接受 NCCN 指南、原创研究论文、综述、社论、评论以及关于肿瘤学界关注主题的专题报告。

History

Founding: the Journal of the National Comprehensive Cancer Network was founded in 2003 by the National Comprehensive Cancer Network, established to publish the NCCN Clinical Practice Guidelines and original oncology research.创刊：《美国国家综合癌症网络杂志》于 2003 年由美国国家综合癌症网络创办，旨在发表 NCCN 临床实践指南与原创肿瘤学研究。
NCCN publication: the journal is the official journal of the National Comprehensive Cancer Network, a non-profit alliance of leading cancer centres in the United States, published by Harborside Press.NCCN 出版：该刊是美国国家综合癌症网络的官方期刊，该网络是美国顶尖癌症中心的非营利联盟，刊物由 Harborside Press 出版。
Guideline focus: since its founding the journal has served as the primary publication outlet for the NCCN Guidelines, which are widely used as standards of cancer care in the United States and internationally.指南定位：自创刊以来该刊一直是 NCCN 指南的主要发表平台，该指南被广泛用作美国乃至国际的癌症治疗标准。
Editorial leadership: the journal has been led by a series of distinguished oncologists, with Daniel M. Geynisman serving as editor-in-chief since May 2024, succeeding Margaret Tempero.编辑领导：该刊由多位杰出肿瘤学家先后领导，丹尼尔·M. 盖尼斯曼（Daniel M. Geynisman）于 2024 年 5 月接任主编，接替玛格丽特·坦佩罗（Margaret Tempero）。

Editors

The journal is led by an editor-in-chief supported by associate editors and an editorial board:该刊由主编领导，副编辑与编委会协助工作：

Editor-in-chief: Daniel M. Geynisman, M.D., Associate Professor in the Department of Hematology/Oncology at Fox Chase Cancer Center, serves as editor-in-chief since May 2024.主编：福克斯·蔡斯癌症中心血液学/肿瘤学系副教授丹尼尔·M. 盖尼斯曼（Daniel M. Geynisman）医学博士自 2024 年 5 月起担任主编。
Associate editors: the journal is supported by associate editors with expertise in key areas of oncology, including medical oncology, radiation oncology, and surgical oncology.副编辑：该刊由具备肿瘤学关键领域专长的副编辑支持，涵盖内科肿瘤学、放射肿瘤学与外科肿瘤学等。
Editorial board: the journal has an editorial board comprising oncologists and researchers from leading cancer centres and institutions worldwide.编委会：该刊编委会由来自全球顶尖癌症中心与机构的肿瘤学家与研究人员组成。
Review model: manuscripts undergo peer review by external experts in oncology, with editorial decisions based on scientific quality, novelty, and clinical significance for cancer care.评审模式：稿件由肿瘤学领域外部专家进行同行评审，编辑决定基于科学质量、新颖性以及对癌症治疗的临床意义做出。